Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab Meeting Abstract

Industry Collaboration

cited authors

  • Konstantinopoulos, P. A.; Munster, P.; Forero-Torez, A.; Holloway, R. W.; Schwartzberg, L.; Matulonis, U. A.; Wang, J.; Guo, W.; Dezube, B.; Vinayak, S.

authors

Publication Date

  • June 1, 2018

webpage

published in

category

start page

  • 246

end page

  • 246

volume

  • 149